VEGFA and neoplasm: Bevacizumab (Avastin®) is a recombinant humanized monoclonal IgG1 antibody that binds to the human vascular endothelial growth factor (VEGF) which is essential for both the normal cell and tumor angiogenesis (Li and Kroetz, 2018).